Active	Status	Sponsor type	Region	Phase	Filter
13 Active 0 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zambello, Renato
iinnovate-1, NCT03215030 / 2021-006038-37: A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma	Completed	1/2	272	Europe, Canada, Japan, US, RoW	Modakafusp alfa, TAK-573, TEV-48573, Dexamethasone	Takeda, Takeda Development Center Americas, Inc.	Multiple Myeloma	07/24	11/24
Visentin, Andrea
NCT06588478: A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	Recruiting	2	249	Europe, Canada, US, RoW	Pirtobrutinib	Loxo Oncology, Inc., Eli Lilly and Company	Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma	06/28	12/28
ARISE, NCT06205498: Acalabrutinib Real World Italian obSErvational Study -	Recruiting	N/A	190	Europe	acalabrutinib, Calquence	AstraZeneca, Yghea	Chronic Lymphocytic Leukemia	02/30	02/30
Binotto, Gianni
ERNEST-3, NCT06533813: Clinical Epidemiology in Contemporary Patients With Myelofibrosis.	Recruiting	N/A	617	Europe, RoW		FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS, GlaxoSmithKline	Myelofibrosis	12/25	12/28
Binotto
No trials found
Gurrieri
No trials found
Lessi, Federica
No trials found
Gurrieri, Carmela
No trials found